Immunotherapy Toxicities Nursing Tumor Board

Description

IGCS nursing workgroup held their first tumor board and discussed nursing care options for a cervical cancer patient experiencing immunotherapy toxicities. The next tumor board will be planned for March.

Case presentation by Sarah Belton, RN (Ireland)
Moderated by Anne Mellon, RN (Australia) and Chrissy Donovan, RN (USA)

Interested in joining future IGCS nursing tumor boards, or have a case you would like to present for discussion, please contact education@igcs.org.

Summary


Availability:	On-Demand


Cost:	FREE

Create Account

Recommended

IGCS 2024 Nursing Symposium

$0.00 - $25.00

Nursing Certificate Program

This curriculum equips nurses with the necessary knowledge to provide evidence-based nursing care to women with gynecological cancer and empowers them to advocate for women to achieve best possible health outcomes.

$0.00 - $75.00

IGCS 2024 Cervical Master Sessions: Moving Fowards

FREE

Journal Club: Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer

FREE

Journal Club: The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial

FREE

Phase II PICCOLO Trial Results

Results of Phase II PICCOLO Trial are available. Dr. Angeles Alvarez Secord, PI of PICCOLO Trial, and Dr. Wendel Naumann discuss results of MIRV in Recurrent Platinum-Sensitive Ovarian Cancer with High Folate Receptor-Alpha Expression.

FREE

Mismatch repair endometrial cancer, what to do at first recurrence and beyond?

FREE

Multidisciplinary Approach to Treating Advanced Endometrial Cancer

FREE

Multidisciplinary Approach to Treating Advanced Endometrial Cancer - Webinar

FREE

Overall Survival Data with PARP Inhibitor: Myth vs. Reality - Webinar

FREE